Artículos de revistas
Expression and function of TLR4- induced B1R bradykinin receptor on cardiac fibroblasts
Fecha
2018Registro en:
Toxicology and Applied Pharmacology, Volumen 351,
10960333
0041008X
10.1016/j.taap.2018.05.011
Autor
Muñoz Rodríguez, Claudia Muriel
Fernández, Samuel
Osorio, José Miguel
Olivares, Francisco
Anfossi, Renatto
Bolivar, Samir
Humeres, Claudio
Boza Fuentes, Pía
Vivar, Raúl
Pardo Jiménez, Viviana Gladys
Hemmings, Karen E.
Turner, Neil A.
Díaz Araya, Guillermo
Institución
Resumen
© 2018 Elsevier Inc. Cardiac fibroblasts (CF) are key cells for maintaining extracellular matrix (ECM) protein homeostasis in the heart, and for cardiac repair through CF-to-cardiac myofibroblast (CMF) differentiation. Additionally, CF play an important role in the inflammatory process after cardiac injury, and they express Toll like receptor 4 (TLR4), B1 and B2 bradykinin receptors (B1R and B2R) which are important in the inflammatory response. B1R and B2R are induced by proinflammatory cytokines and their activation by bradykinin (BK: B2R agonist) or des-arg-kallidin (DAKD: B1R agonist), induces NO and PGI2 production which is key for reducing collagen I levels. However, whether TLR4 activation regulates bradykinin receptor expression remains unknown. CF were isolated from human, neonatal rat and adult mouse heart. B1R mRNA expression was evaluated by qRT-PCR, whereas B1R, collagen, COX-2 and iNOS protein levels were evaluated by Western Blot. NO and PGI2 were evaluated by commercial